The Effect of a Continuous 1-Hour Time Delay on Circadian Rhythms
2 other identifiers
interventional
40
1 country
1
Brief Summary
The purpose of this study is to investigate whether the experience of a daily time delay can affect our internal circadian rhythm.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Dec 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 19, 2025
CompletedStudy Start
First participant enrolled
December 20, 2025
CompletedFirst Posted
Study publicly available on registry
January 5, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
August 30, 2027
January 16, 2026
December 1, 2025
1.2 years
December 19, 2025
January 14, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Phase shift in circadian rhythm markers
The primary outcome is the timing of dim light melatonin onset, a marker of circadian phase. Saliva samples will be collected at regular intervals under dim light, and the time when melatonin exceeds 3 pg/mL will be recorded for each participant. This allows measurement of circadian phase shifts across conditions.
Comparing samples on days 1, 3, 5
Secondary Outcomes (1)
Psychomotor Vigilance Task (PVT) Median Reaction Time
Performance will be measured at regular intervals on days 1 - 5 to track changes over the course of the study.
Study Arms (2)
Fixed daily routine
EXPERIMENTALAll activities occur at the same time every day. During the five days, participants will have to complete various daily tests and also be asked to provide 8 saliva samples during days 1, 3, and 5
Daily time delay of 1 hour
EXPERIMENTALAll activities will be delayed by one hour. During the five days, participants will have to complete various daily tests and also be asked to provide 8 saliva samples during days 1, 3, and 5
Interventions
All activities will be delayed by one hour per day over a 5 day period.
Eligibility Criteria
You may qualify if:
- Healthy adults aged 23-45 years
- Part of a heterosexual, cohabiting couple willing to participate together in a five-day in-laboratory study
- Completion of at least upper-secondary education
- Maintain a regular sleep-wake schedule
- Habitual sleep timing within a normative range (non-extreme chronotype), assessed using the Morningness-Eveningness Questionnaire (MEQ) or the Munich Chronotype Questionnaire (MCTQ)
- Both partners fall within the acceptable chronotype range to ensure aligned sleep-wake patterns
- Low seasonality scores on the Seasonal Pattern Assessment Questionnaire (SPAQ)
- Free from underlying sleep or mood disorders
You may not qualify if:
- Engages in night-shift work or maintains an irregular work or sleep schedule
- International travel involving a time-zone change of more than two hours within the past two months, or anticipated travel before study completion
- Diagnosed neurological, psychiatric, or sleep disorder (e.g., insomnia, sleep apnea, bipolar disorder)
- High risk of sleep apnea, defined as a Berlin Questionnaire score \>2 (Lauritzen et al., 2018)
- Use of medications known to affect sleep, alertness, melatonin secretion, or circadian timing
- Unable or unwilling to comply with behavioral restrictions, including refraining from electronic devices displaying time cues unless clocks are removed and devices are disconnected from Wi-Fi
- Unable or unwilling to comply with consumption restrictions, including abstaining from caffeine, alcohol, and melatonin-rich foods during the study
- Extreme chronotype, defined as a habitual midsleep time outside 03:00-05:00 on the MCTQ or classification as an extreme morning or extreme evening type on the MEQ
- Daily caffeine consumption exceeding 400 mg (approximately 4-5 cups of coffee)
- Current smoker or smoking within the past six months
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Aarhuslead
- Independent Research Fund Denmarkcollaborator
Study Sites (1)
Aarhus University, Department of Psychology and Behavioural Sciences
Aarhus, 8000, Denmark
Related Links
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Masking Details
- Open-label, single-group basic science study; no masking used.
- Purpose
- BASIC SCIENCE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 19, 2025
First Posted
January 5, 2026
Study Start
December 20, 2025
Primary Completion (Estimated)
March 1, 2027
Study Completion (Estimated)
August 30, 2027
Last Updated
January 16, 2026
Record last verified: 2025-12
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ANALYTIC CODE
- Time Frame
- De-identified individual participant data and supporting documents will be made available beginning within 12 months after publication of the main results article and will remain available for at least 5 years thereafter.
- Access Criteria
- De-identified individual participant data (IPD), together with the study protocol, statistical analysis plan, and analytic code, will be available to qualified researchers affiliated with recognised research institutions who submit a methodologically sound proposal and obtain any required ethical or institutional approvals. Requests should describe the planned analyses and data needed. Approved requesters will sign a data use agreement prohibiting re-identification of participants and requiring appropriate data security. Data will be shared via secure transfer or a controlled-access repository approved by Aarhus University.
De-identified individual participant data (IPD) underlying the published results will be shared with other researchers upon reasonable request, in accordance with Danish data protection regulations, institutional policies, and ethics approval. Data will be pseudonymised before sharing and no direct identifiers (e.g., name, contact details, personal ID numbers) will be included. Any data elements that could reasonably lead to re-identification in combination with other information will be removed or aggregated where necessary.